Home › Research › Disease mechanisms
Targeting anaplastic lymphoma kinase (ALK) alleviates synaptic dysfunction associated with C9orf72 haploinsufficiency
Bryan Kartono, Liliana Attisano, Janice Robertson. Alzheimer s & Dementia, 2025-12-01
Topic: Brain proteins, microglia and lab models
Primary cortical neurons with C9orf72 haploinsufficiency exhibit alterations in dendritic branching, indicating disrupted neuronal connectivity. Additionally, C9orf72 haploinsufficiency increases neuronal vulnerability to excitotoxicity and cell death under stress, evidenced by reduced viability following high glutamate exposure. Glutamate excitotoxicity is a common pathomechanism in neurodegenerative diseases, including FTD/ALS. This can be explained by elevated calcium-permeable AMPAR subunit GluA1 levels at post-synaptic sites, increasing vulnerability. These synaptic dysfunction phenotypes arise from aberrant activity of interrelated PI3K/Akt and LIMK1/cofilin pathways. Importantly, inhibition of ALK by lorlatinib rescues dendritic complexity and enhances neuronal resilience to glutamate-induced damage by normalizing PI3K/Akt and LIMK1/cofilin activity. Lorlatinib may mitigate synaptic dysfunction and preserve neuronal connectivity, addressing key pathomechanisms underlying C9orf72-FTD. Our findings highlight the therapeutic potential of lorlatinib, an ALK inhibitor, in mitigating synaptic deficits caused by C9orf72 haploinsufficiency. We emphasize the role of synaptic pathology in C9orf72-FTD pathogenesis and suggest that targeting ALK with drugs like lorlatinib could offer promising therapeutic strategies for treating synaptic dysfunction caused by C9orf72 haploinsufficiency.
Key findings
- Primary cortical neurons with C9orf72 haploinsufficiency exhibit alterations in dendritic branching, indicating disrupted neuronal connectivity.
- Additionally, C9orf72 haploinsufficiency increases neuronal vulnerability to excitotoxicity and cell death under stress, evidenced by reduced viability following high glutamate exposure.
- Glutamate excitotoxicity is a common pathomechanism in neurodegenerative diseases, including FTD/ALS.
- This can be explained by elevated calcium-permeable AMPAR subunit GluA1 levels at post-synaptic sites, increasing vulnerability.
- These synaptic dysfunction phenotypes arise from aberrant activity of interrelated PI3K/Akt and LIMK1/cofilin pathways.
Why it matters
In cultured neurons with C9orf72 haploinsufficiency, the ALK inhibitor lorlatinib rescued dendritic complexity and improved resilience to glutamate-induced damage. These are cell-based findings related to C9orf72-FTD, not evidence of treating, curing or preventing Alzheimer's disease.
Study details
- Evidence strengthLow
How this study scored 31/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomised / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Alzheimer s & Dementia) |
| Journal's citation record | 2 / 4 | Alzheimer s & Dementia: journal h-index 228 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomised / blinded | 0 / 2 | No randomisation or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 0 / 7 | Cited 0 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.0 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 0 / 6 | Cited 0.0× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 1 / 4 | Last-listed author Janice Robertson: h-index 5 (OpenAlex, whole career) |
| Institution's track record | 2 / 3 | University of Toronto: institution h-index 1,923 (OpenAlex) |
| Multi-centre collaboration | 0 / 3 | OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 41436064) |
| Free to read | 2 / 2 | Free to read |
| Total | 31 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1002/alz70855_099957
- PubMed: 41436064
- Original source →
- Free full text: Alzheimer s & Dementia →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
APA 7th
Kartono, B., Attisano, L., & Robertson, J. (2025). Targeting anaplastic lymphoma kinase (ALK) alleviates synaptic dysfunction associated with C9orf72 haploinsufficiency. Alzheimer s & Dementia. https://doi.org/10.1002/alz70855_099957
Vancouver
Kartono B, Attisano L, Robertson J. Targeting anaplastic lymphoma kinase (ALK) alleviates synaptic dysfunction associated with C9orf72 haploinsufficiency. Alzheimer s & Dementia. 2025. doi:10.1002/alz70855_099957. PMID: 41436064.
BibTeX
@article{kartono2025-41436064,
author = {Kartono, Bryan and Attisano, Liliana and Robertson, Janice},
title = {{Targeting anaplastic lymphoma kinase (ALK) alleviates synaptic dysfunction associated with C9orf72 haploinsufficiency}},
journal = {Alzheimer s \& Dementia},
year = {2025},
doi = {10.1002/alz70855_099957},
pmid = {41436064},
url = {https://doi.org/10.1002/alz70855_099957}
}
Related studies in Disease mechanisms
Also tagged “mice”
1,150 studies in the library carry the topic tag “mice”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,150 tagged studies.